Pharmaceutical Company Lek Boosts Sales on all Major Markets
Ljubljana, 14 November - Slovene pharmaceutical company Lek recorded sales revenues of SIT 50.4 billion (EUR 228 million) in the first nine months of this year, a jump of 24.4 percent over the same period last year, the company reported on Wednesday.
The rest of this news item is available to subscribers.
The news item consists of 853 characters (without spaces) or 164 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.